SEARCH
ICMR recommends anti-malarial drug for high-risk coronavirus cases
Aaj Tak
2020-07-02
Views
4
Description
Share / Embed
Download This Video
Report
The National Task Force constituted by the Indian Council of Medical Research (ICMR) has recommended the use of hydroxychloroquine for the treatment of high-risk coronavirus cases.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x7sw1dy" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
01:01
AIIMS panel gives nod to human clinical trial of anti-coronavirus drug Covaxin
01:25
Anti-malaria drug hydroxychloroquine’s coronavirus trials to resume, says WHO
04:18
How DRDO's anti-covid drug cheats the coronavirus?
07:30
2.31 lakh samples tested for coronavirus so far: ICMR
08:49
Coronavirus in India currently in stage 2, no signs of community transmission yet: ICMR
33:02
Watch: Premature to forecast coronavirus lockdown end, says ICMR chief scientist
12:44
Coronavirus: Police, Doctors risks life to save others
06:40
Coronavirus new strain poses risks for Britain
45:10
Coronavirus: India's virus-villains putting lives of others at risk! | Watch
05:05
Exclusive| Is dexamethasone life-saving coronavirus drug: Expert explains
12:38
Panel recommends phase 2/3 trials of Covaxin on children
02:22
UP govt recommends CBI probe in Manish Gupta murder
